SARS-CoV-2 M pro inhibitors: identification of anti-SARS-CoV-2 M pro compounds from FDA approved drugs
Article
Published on
Journal: Journal of biomolecular structure & dynamics [Category] COVID19(2023년), SARS, 신약개발,
Journal: Journal of biomolecular structure & dynamics [Category] COVID19(2023년), SARS, 신약개발,
[키워드] Analysis
anti-SARS-CoV-2
binding affinity
binding free energy
caused
complex
Compound
Coronavirus replication
Correlation analysis
COVID-19
COVID-19 pandemic
cysteine protease
database
docking
drug
Drug discovery
Drug repurposing
end point
enzyme
FDA approved drug
in vitro
in vivo
Interaction
Ligand
M pro
molecular
molecular docking
Molecular dynamics simulation
Molecular simulation
N3 inhibitor
outbreak
public health
R428
raised
recent
SARS-CoV-2
screened
stability
Structure-based virtual screening
Teniposide
viral life cycle
Virtual screening
VS-5584
[DOI] 10.1080/07391102.2020.1842807 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/07391102.2020.1842807 PMC 바로가기 [Article Type] Article